Commonly Used Drug Might Be New Treatment Option for IBS
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS). In the study, British researchers found that those taking amitriptyline wereContinue Reading